Enterprise Financial Services Corp (EFSC)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-58
Closed -$18K 1299
2021
Q2
$18K Buy
58
+19
+49% +$5.83K ﹤0.01% 615
2021
Q1
$12K Hold
39
﹤0.01% 737
2020
Q4
$12K Hold
39
﹤0.01% 686
2020
Q3
$11K Hold
39
﹤0.01% 687
2020
Q2
$9K Sell
39
-2
-5% -$402 ﹤0.01% 731
2020
Q1
$6K Buy
41
+31
+310% +$5.15K ﹤0.01% 778
2019
Q4
$2K Hold
10
﹤0.01% 1035
2019
Q3
$2K Sell
10
-9
-47% -$1.95K ﹤0.01% 1027
2019
Q2
$5K Buy
19
+9
+90% +$2.39K ﹤0.01% 907
2019
Q1
$3K Hold
10
﹤0.01% 1009
2018
Q4
$3K Sell
10
-15
-60% -$5.21K ﹤0.01% 786
2018
Q3
$11K Buy
25
+15
+150% +$5.91K 0.01% 578
2018
Q2
$4K Hold
10
﹤0.01% 782
2018
Q1
$3K Hold
10
﹤0.01% 804
2017
Q4
$2K Hold
10
﹤0.01% 839
2017
Q3
$2K Hold
10
﹤0.01% 854
2017
Q2
$1K Sell
10
-19
-66% -$2.55K ﹤0.01% 917
2017
Q1
$4K Hold
29
﹤0.01% 824
2016
Q4
$3K Buy
29
+10
+53% +$1.16K ﹤0.01% 880
2016
Q3
$2K Hold
19
﹤0.01% 910
2016
Q2
$2K Hold
19
﹤0.01% 887
2016
Q1
$2K Buy
+19
New +$1.6K ﹤0.01% 908

Other funds holding ABMD

Enterprise Financial Services Corp (EFSC)'s ABMD Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 58 shares — an estimated $18K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ABMD in Q1 2016 and held it in 22 quarters. The position peaked at $18K in Q2 2021. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 58 Abiomed Inc shares in Q3 2021, an estimated $18K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Abiomed Inc in Q1 2016 and held it in 22 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Abiomed Inc position peaked at $18K in Q2 2021.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.